1 / 1

Discrimination Between Neoplastic and Normal B-Cells in Lymphoma Patients

Supplementary Figure 1 illustrates discrimination between neoplastic and normal residual B-cells in CD19+ gate using bone marrow and peripheral blood samples from lymphoma patients. Case 1: Panels show markers CD23, CD10, cyBCL2, CD22. Case 2: Markers include KAPPA, LAMBDA, CD5.

warren
Download Presentation

Discrimination Between Neoplastic and Normal B-Cells in Lymphoma Patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplementary Figure 1 Illustrating examples about the discrimination between neoplastic and normal residual B-cells contained in the CD19+ B-cell gate of a bone marrow sample from a follicular lymphoma patient (case 1: panels A to D); and a peripheral blood sample from a mantle cell lymphoma (case 2; panels E to H) Case 1: B C D A CD23 PE SSC-Exp CD10 PE SSC-Exp cyBCL2 FITC CD22 FITC CD19 PerCP-Cy5.5 FSC Case 2: E H G F SSC-Exp SSC-Ecp KAPPA PE CD19 PERCPCY5.5 FSC CD19 PERCP-Cy5.5 CD5 APC LAMBDA FITC

More Related